Literature DB >> 26869175

Effects of Pump Pulsation on Hydrodynamic Properties and Dissolution Profiles in Flow-Through Dissolution Systems (USP 4).

Hiroyuki Yoshida1, Akemi Kuwana2, Hiroko Shibata2, Ken-Ichi Izutsu2, Yukihiro Goda2.   

Abstract

PURPOSE: To clarify the effects of pump pulsation and flow-through cell (FTC) dissolution system settings on the hydrodynamic properties and dissolution profiles of model formulations.
METHODS: Two FTC systems with different cell temperature control mechanisms were used. Particle image velocimetry (PIV) was used to analyze the hydrodynamic properties of test solutions in the flow-through dissolution test cell. Two pulsation pumps (semi-sine, full-sine) and a non-pulsatile pump were used to study the effects of varied flows on the dissolution profiles of United States Pharmacopeia standard tablets.
RESULTS: PIV analysis showed periodic changes in the aligned upward fluid flow throughout the dissolution cell that was designed to reduce the temperature gradient during pump pulsation (0.5 s/pulse). The maximum instantaneous flow from the semi-sine pump was higher than that of the full-sine pump under all conditions. The flow from the semi-sine wave pump showed faster dissolution of salicylic acid and prednisone tablets than those from other pumps. The semi-sine wave pump flow showed similar dissolution profiles in the two FTC systems.
CONCLUSIONS: Variations in instantaneous fluid flow caused by pump pulsation that meets the requirements of pharmacopoeias are a factor that affects the dissolution profiles of tablets in FTC systems.

Entities:  

Keywords:  dissolution testing; flow-through cell system; hydrodynamics; pulsatile pump

Mesh:

Substances:

Year:  2016        PMID: 26869175     DOI: 10.1007/s11095-016-1874-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Hydrodynamic flows around tablets in different pharmacopeial dissolution tests.

Authors:  M Morihara; N Aoyagi; N Kaniwa; N Katori; S Kojim
Journal:  Drug Dev Ind Pharm       Date:  2002-07       Impact factor: 3.225

2.  MRI technique for the snapshot imaging of quantitative velocity maps using RARE.

Authors:  G Shiko; A J Sederman; L F Gladden
Journal:  J Magn Reson       Date:  2012-02-08       Impact factor: 2.229

3.  Hydrodynamics-induced variability in the USP apparatus II dissolution test.

Authors:  Jennifer L Baxter; Joseph Kukura; Fernando J Muzzio
Journal:  Int J Pharm       Date:  2005-03-23       Impact factor: 5.875

4.  Classification of the flow regimes in the flow-through cell.

Authors:  Maziar Kakhi
Journal:  Eur J Pharm Sci       Date:  2009-04-18       Impact factor: 4.384

5.  Mathematical modeling of the fluid dynamics in the flow-through cell.

Authors:  Maziar Kakhi
Journal:  Int J Pharm       Date:  2009-04-16       Impact factor: 5.875

6.  Hydrodynamic and species transfer simulations in the USP 4 dissolution apparatus: considerations for dissolution in a low velocity pulsing flow.

Authors:  Deirdre M D'Arcy; Bo Liu; Geoff Bradley; Anne Marie Healy; Owen I Corrigan
Journal:  Pharm Res       Date:  2009-12-10       Impact factor: 4.200

7.  Particle Image Velocimetry Evaluation of Fluid Flow Profiles in USP 4 Flow-Through Dissolution Cells.

Authors:  Hiroyuki Yoshida; Akemi Kuwana; Hiroko Shibata; Ken-Ichi Izutsu; Yukihiro Goda
Journal:  Pharm Res       Date:  2015-03-20       Impact factor: 4.200

8.  Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system.

Authors:  H Möller; E Wirbitzki
Journal:  Boll Chim Farm       Date:  1993-04

9.  Development of a performance verification test for USP apparatus 4.

Authors:  Joseph W Eaton; Daren Tran; Walter W Hauck; Erika S Stippler
Journal:  Pharm Res       Date:  2011-08-09       Impact factor: 4.200

10.  Investigating the effect of solubility and density gradients on local hydrodynamics and drug dissolution in the USP 4 dissolution apparatus.

Authors:  Deirdre M D'Arcy; Bo Liu; Owen I Corrigan
Journal:  Int J Pharm       Date:  2011-08-06       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.